• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺二氯二氨合铂(II)的体外联合化疗

Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).

作者信息

Drewinko B, Green C, Loo T L

出版信息

Cancer Treat Rep. 1976 Nov;60(11):1619-25.

PMID:1021234
Abstract

Cis-dichlorodiammineplatinum(II) (DDP) was paired with 11 other chemotherapeutic drugs in a search for possible synergistic pairs. Cell lethality was investigated by the colony-formation technique utilizing a long-term culture of human lymphoma cells. Synergistic effects were noted for pair combinations with all alkylating agents, bleomycin, adriamycin, camptothecin, and cytosine arabinoside. Additive effects were recorded for combinations with prednisolone and VP-16-213, while DDP reduced the capacity of cells to absorb sublethal damage induced by alkylating agents.

摘要

顺二氯二氨铂(II)(DDP)与其他11种化疗药物配对,以寻找可能的协同组合。利用人淋巴瘤细胞的长期培养,通过集落形成技术研究细胞杀伤力。发现与所有烷化剂、博来霉素、阿霉素、喜树碱和阿糖胞苷的配对组合具有协同作用。与泼尼松龙和依托泊苷的组合记录为相加作用,而DDP降低了细胞吸收烷化剂诱导的亚致死损伤的能力。

相似文献

1
Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).顺二氯二氨合铂(II)的体外联合化疗
Cancer Treat Rep. 1976 Nov;60(11):1619-25.
2
Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells.阿霉素体外联合化疗。观察其与其他药物联合用于培养的人淋巴瘤细胞时的相加、拮抗和协同作用。
Cancer Biochem Biophys. 1976 May;1(4):187-95.
3
Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.体外联合化疗。IV. 人结肠癌细胞对顺二氯二氨铂联合用药的反应
Cancer Biochem Biophys. 1979;3(4):173-80.
4
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.烷化剂:人类细胞系中交叉耐药模式的体外研究
Cancer Res. 1986 Sep;46(9):4379-83.
5
Cellular response to treatment with 4-(3-(2-chloroethyl)-3-nitrosoureido)-cis-cyclohexanecarboxylic acid, a water-soluble nitrosourea derivative.细胞对4-(3-(2-氯乙基)-3-亚硝基脲基)-顺式环己烷羧酸(一种水溶性亚硝基脲衍生物)治疗的反应。
Cancer Treat Rep. 1977 Nov;61(8):1513-8.
6
Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro.顺二氯二氨铂(II)对人NHIK 3025细胞的氧和温度依赖性细胞毒性及放射增敏作用的体外研究
Radiat Res. 1988 Jun;114(3):489-99.
7
Preclinical studies and clinical correlation of the effect of alkylating dose.烷化剂量效应的临床前研究与临床相关性
Cancer Res. 1988 Nov 15;48(22):6417-23.
8
Cytostatic activity in vitro of new cis-dichlorodiammineplatinum (II) analogs.新型顺二氯二氨铂(II)类似物的体外细胞抑制活性
Arch Immunol Ther Exp (Warsz). 1982;30(5-6):357-61.
9
Combination effects of cis-dichlorodiammineplatinum with selected metahalones, pyrimidine sulfoxides and pyrimidine sulfones on human NHIK 3025 cells in vitro.顺二氯二氨铂与选定的卤代甲烷、嘧啶亚砜和嘧啶砜在体外对人NHIK 3025细胞的联合作用
Anticancer Drug Des. 1988 Dec;3(3):191-8.
10
Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro.顺二氯二氨合铂(II)对人结肠癌细胞的体外作用。
Cancer Res. 1979 Apr;39(4):1334-8.

引用本文的文献

1
Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim.FNIII14肽的联合给药通过激活促凋亡蛋白Bim协同增强化疗药物的抗癌活性。
PLoS One. 2016 Sep 13;11(9):e0162525. doi: 10.1371/journal.pone.0162525. eCollection 2016.
2
Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells.虫草素联合顺铂和/或紫杉醇对MA-10小鼠睾丸间质细胞瘤细胞的凋亡作用。
Onco Targets Ther. 2015 Sep 1;8:2345-60. doi: 10.2147/OTT.S87010. eCollection 2015.
3
A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma.
c-Met 抑制剂增加胃癌肿瘤干细胞对伊立替康的化疗敏感性。
Br J Cancer. 2013 Nov 12;109(10):2619-28. doi: 10.1038/bjc.2013.638. Epub 2013 Oct 15.
4
Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer.mTOR 抑制剂联合氟尿嘧啶对硬纤维瘤胃癌的协同抗增殖作用。
Cancer Sci. 2009 Dec;100(12):2402-10. doi: 10.1111/j.1349-7006.2009.01315.x. Epub 2009 Aug 18.
5
A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.盐酸尼莫司汀、顺铂和依托泊苷联合化疗治疗幕上恶性胶质瘤的II期研究。
J Neurooncol. 2000 Sep;49(3):213-8. doi: 10.1023/a:1006486528418.
6
Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines.拓扑替康与多种活性G2/M期抗癌药物联合应用对人肿瘤衍生细胞系的细胞毒性作用。
Invest New Drugs. 2000 May;18(2):139-47. doi: 10.1023/a:1006325929424.
7
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.丝裂霉素C、阿霉素、顺铂诱导化疗联合每周5-氟尿嘧啶、亚叶酸钙维持化疗治疗转移性鼻咽癌:一项II期研究
Br J Cancer. 1999 Aug;80(12):1962-7. doi: 10.1038/sj.bjc.6690627.
8
Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.在小鼠肿瘤中,将拓扑异构酶I抑制剂添加到三联疗法[顺二氯二氨铂(II)/热/辐射]中。
J Cancer Res Clin Oncol. 1993;119(11):645-51. doi: 10.1007/BF01215982.
9
EPIC: an effective low toxicity regimen for relapsing lymphoma.EPIC:一种用于复发性淋巴瘤的有效低毒性方案。
Br J Cancer. 1993 Sep;68(3):599-604. doi: 10.1038/bjc.1993.393.
10
Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.新生霉素、拓扑替康和氯尼达明对抗肿瘤烷化剂的调节作用。
Cancer Chemother Pharmacol. 1993;32(6):455-62. doi: 10.1007/BF00685890.